2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)

被引：0
|
作者：
S Yokota
T Imagawa
T Miyamae
K Kasai
M Mori
N Nishimoto
T Kishimoto
机构：
[1] Yokohama City University,
[2] Osaka University,undefined
来源：
Pediatric Rheumatology | / 6卷 / Suppl 1期
关键词：
Corticosteroid; Respiratory Tract Infection; Juvenile Idiopathic Arthritis; Gastroenteritis; Tocilizumab;
D O I：
10.1186/1546-0096-6-S1-S1
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A lifelong journey: Long-term perspectives on Juvenile Idiopathic Arthritis
    Ramos, Filipa Oliveira
    Zinterl, Carolina
    Fonseca, Joao Eurico
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2024, 38 (03):
  • [42] Subcutaneous Tocilizumab for Cystoid Macular Edema Secondary to Juvenile Idiopathic Arthritis (JIA)-associated Uveitis: A Case Report
    Adan, Alfredo
    Moll-Udina, Aina
    Ramirez, Julio
    Llorenc, Victor
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (01) : 6 - 8
  • [43] Toward an understanding of the long-term outcome of juvenile idiopathic arthritis
    Ravelli, A
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (03) : 271 - 275
  • [44] Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab
    Yokota, Shumpei
    Itoh, Yasuhiko
    Morio, Tomohiro
    Sumitomo, Naokata
    Daimaru, Kaori
    Minota, Seiji
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (04) : 712 - 722
  • [45] Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study
    Iwata, Naomi
    Nishimura, Kenichi
    Hara, Ryoki
    Imagawa, Tomoyuki
    Shimizu, Masaki
    Tomiita, Minako
    Umebayashi, Hiroaki
    Takei, Syuji
    Seko, Noriko
    Wakabayashi, Ryota
    Yokota, Shumpei
    MODERN RHEUMATOLOGY, 2023, 33 (06) : 1162 - 1170
  • [46] Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis
    Takako Miyamae
    Tomo Nozawa
    Masako Kikuchi
    Toshitaka Kizawa
    Tomoyuki Imagawa
    Shumpei Yokota
    Pediatric Rheumatology, 9 (Suppl 1)
  • [47] Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab
    Shinoki, Toshihiko
    Hara, Ryoki
    Kaneko, Utako
    Miyamae, Takako
    Imagawa, Tomoyuki
    Mori, Masaaki
    Yokota, Shumpei
    MODERN RHEUMATOLOGY, 2012, 22 (06) : 871 - 876
  • [48] Effects of antirheumatic treatment with tocilizumab on longitudinal growth in children with juvenile idiopathic arthritis
    Ekaterina Alexeeva
    Rina Denisova
    Sanya Valieva
    Tatyana Bzarova
    Ksenya Isayeva
    Tatyana Sleptsova
    Evgeniya Chistyakova
    Anna Fetisova
    Olga Lomakina
    Pediatric Rheumatology, 12 (Suppl 1)
  • [49] PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients
    P Lu
    J Hsu
    C Keane
    S Fettner
    J Wang
    N Ruperto
    O Harari
    HI Brunner
    F De Benedetti
    Pediatric Rheumatology, 11 (Suppl 2)
  • [50] Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan
    Mori, Masaaki
    Takei, Syuji
    Imagawa, Tomoyuki
    Imanaka, Hiroyuki
    Nerome, Yasuhito
    Higuchi, Rumiko
    Kawano, Yoshifumi
    Yokota, Shumpei
    Sugiyama, Noriko
    Yuasa, Hirotoshi
    Fletcher, Tracey
    Wajdula, Joseph S.
    MODERN RHEUMATOLOGY, 2012, 22 (05) : 720 - 726
12345